Form 8-K: Teladoc Health, Inc. Annual Meeting of Stockholders Results

Teladoc Health, Inc. held its 2026 Annual Meeting of Stockholders on May 21, 2026. The stockholders elected all director nominees proposed by the Board of Directors. Additionally, the stockholders approved, on an advisory basis, the compensation of the Company's named executive officers. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026, was also ratified. The filing details the voting results for each of these proposals, including votes for, against, abstentions, and broker non-votes where applicable. The report was signed by Adam C. Vandervoort, Chief Legal Officer and Secretary, on May 21, 2026.